| Pharmaceutical active ingredients: |
| BendroflumethiazideHydralazine HydrochloridePropranolol Hydrochloride |
| Available forms, composition and doses of Pertenso N: |
| Capsules; Oral; Bendroflumethiazide; Hydralazine Hydrochloride; Propranolol Hydrochloride |
| Pertenso N medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07BA05 - Propranolol and thiazides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Fournier |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Diserim | Bendroflumethiazide; Fluphenazine Hydrochloride | Apsen Farmaceutica |
| Mendrome | Bendroflumethiazide; Fluphenazine Hydrochloride | Bristol-Myers Squibb |
| Sumal | Bendroflumethiazide; Homatropine Methylbromide; Metamizole | Purissimus |
| Betadipresan Diu | Bendroflumethiazide; Hydralazine Hydrochloride; Propranolol Hydrochloride | Rottapharm |
| Docidrazin | Bendroflumethiazide; Hydralazine Hydrochloride; Propranolol Hydrochloride | AstraZeneca |
| Precyclan | Bendroflumethiazide; Medroxyprogesterone Acetate; Meprobamate | Lisapharm Laboratoire |
| Tenavoid | Bendroflumethiazide; Meprobamate | Leo Pharma |
| Seda-Repicin | Bendroflumethiazide; Methiomeprazine Hydrochloride; Reserpine | Boehringer Ingelheim |
| Corgaretic | Bendroflumethiazide; Nadolol | Bristol-Myers Squibb; Sanofi-Aventis |
| Corzide | Bendroflumethiazide; Nadolol | Bristol-Myers Squibb; King Pharmaceuticals |